packageOblimersen

oblimersen

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Oblimersen is an investigational antisense oligonucleotide drug that was studied as a treatment for melanoma. It has never been approved; a marketing application in the European Union was refused, so it remains experimental.

Summary written by glm-5.3-flash from Wikidata Q7075165 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:oblimersen
ATC codes:L01XX36
DrugBank:DB13811
Wikidata:Q7075165

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown